St. Jude Gearing For SCD-HeFT Implants, Anticipates Medicare Rewards
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical will start to reap the benefits of Medicare's coverage policy for implantable cardioverter defibrillators now that CMS has established an ICD registry, the company predicted April 21 during its first-quarter earnings call
You may also be interested in...
Heart Rhythm Society Members Offer CMS Advice On ICD Registry Creation
The National ICD Registry Working Group will collaborate with CMS to establish better definitions for how physicians should record information on the implantable cardioverter defibrillator registry data collection form
Medtronic Foresees Gradual ICD Uptake, Reviews Battery Problem
Demand for Medtronic's implantable cardioverter defibrillators in response to CMS' January coverage decision will increase gradually over the next several quarters rather than in one dramatic surge, according to the company
Ratio Therapeutics On BMS Investment, Radiopharma R&D Trends, AI Use
The CEO and CSO of radiopharmaceutical company Ratio Therapeutics, which now has Bristol Myers Squibb as an investor, talk about Ratio’s R&D platforms, use of AI, an independent FAP-targeted asset and trends in radiopharma research such as combining other modalities like ADCs, in this podcast interview with Scrip